GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Monash IVF Group Ltd (ASX:MVF) » Definitions » 3-Year EBITDA Growth Rate

Monash IVF Group (ASX:MVF) 3-Year EBITDA Growth Rate : -1.10% (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Monash IVF Group 3-Year EBITDA Growth Rate?

Monash IVF Group's EBITDA per Share for the six months ended in Dec. 2023 was A$0.07.

During the past 12 months, Monash IVF Group's average EBITDA Per Share Growth Rate was 30.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -1.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -5.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Monash IVF Group was 0.20% per year. The lowest was -13.90% per year. And the median was -5.60% per year.

Competitive Comparison of Monash IVF Group's 3-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Monash IVF Group's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Monash IVF Group's 3-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Monash IVF Group's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Monash IVF Group's 3-Year EBITDA Growth Rate falls into.


Monash IVF Group 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Monash IVF Group  (ASX:MVF) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Monash IVF Group 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Monash IVF Group's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Monash IVF Group (ASX:MVF) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Monash IVF Group Ltd (ASX:MVF) » Definitions » 3-Year EBITDA Growth Rate
Comparable Companies
ASX:ACL ASX:IDX ASX:MAP ASX:GSS ASX:IIQ ASX:RHY ASX:LDX ASX:CTE ASX:BDX ASX:GTG TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
MIS:Germany
Address
510 Church Street, Level 1, Cremorne, Cremorne, VIC, AUS, 3121
Website
https://www.monashivfgroup.com.au
Monash IVF Group Ltd is a specialist assisted reproductive services provider. The company offers specialist diagnostic obstetric and gynaecological ultrasound and fertility treatments. The company's operating segment includes Australia and International. It generates maximum revenue from the Australian segment. Australian segment is a provider of Assisted Reproductive Services, Ultrasound, and other related services. The International segment is a provider of Assisted Reproductive Services in Malaysia.